<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title><![CDATA[Business]]></title><link/> https://www.economist.com/business/ <atom:link href="https://rsshub.app/economist/business?mode=fulltext" rel="self" type="application/rss+xml"></atom:link><description><![CDATA[Business - Made with love by RSSHub(https://github.com/DIYgod/RSSHub)]]></description><generator> RS集线器</generator><webmaster>i@diygod.me (DIYgod)</webmaster><language> zh-cn</language><lastbuilddate> 2023 年 10 月 10 日，星期二 02:41:01 GMT</lastbuilddate><ttl> 120 </ttl><item><title><![CDATA[Who profits most from America’s baffling health-care system?]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><p class="css-1hno3qs e190yofl0"> <span>10</span><small>月</small>4<small>日，</small>大型医疗连锁机构 Kaiser Permanente 的 75,000 多名员工开始了为期三天的罢工。这次罢工是美国卫生部门历史上规模最大的一次，并引起人们对困扰该国医院和诊所的人员短缺问题的关注。同一周，十家制药商表示，他们将根据几乎迫使他们这样做的立法，与医疗保险（老年人的公共医疗保健系统）协商药品价格。这将是企业首次与政府就价格讨价还价。</p><p class="css-1hno3qs e190yofl0">这些事件是美国功能失调的医疗保健系统更深层次问题的症状。该国每年花费约 4.3 万亿美元来保持公民的良好健康。这相当于<small>GDP</small>的17%，是其他富裕经济体平均水平的两倍。然而，与同样富裕的地方相比，美国成年人的寿命较短，美国婴儿的死亡率更高。制药公司和医院因其高昂的成本而引起了公众的愤怒。人们对少数中间商的关注要少得多，他们从系统的复杂性中获取了更大的租金。 </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231014_EPC868.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231014_EPC868.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231014_EPC868.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231014_EPC868.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231014_EPC868.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231014_EPC868.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231014_EPC868.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231014_EPC868.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231014_EPC868.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231014_EPC868.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231014_EPC868.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231014_EPC868.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231014_EPC868.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231014_EPC868.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231014_EPC868.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231014_EPC868.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231014_EPC868.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">在过去的十年里，这些公司悄然增加了在美国庞大的医疗保健行业的影响力。他们不生产药物，直到最近才开始治疗患者。他们是介于患者和治疗之间的中间人——保险公司、药房、药品分销商和药品福利管理者 ( <small>PBM</small> )。到 2022 年，九家最大的中间商（称为“大健康”）的总收入相当于美国医疗保健账单的 45% 左右，高于 2013 年的 25%。<small>美国</small>收入排名前 25 的公司中，大健康占据了八家。美国领先股票的<small>普</small>500 指数，相比之下，大型科技股有四只，大型制药股则没有。</p><p class="css-1hno3qs e190yofl0">大健康始于一系列寡头垄断。四家私人医疗保险公司占所有投保人数的 50%。最大的联合健康集团去年的收入为 3240 亿美元，仅次于沃尔玛、亚马逊、苹果和埃克森美孚，税前利润为 250 亿美元。其 1.51 亿客户几乎占所有美国人的一半。其市值在过去五年中翻了一番，达到 4,860 亿美元，在美国最有价值公司中排名第 12 位。四大制药巨头创造了美国 60% 的药品配发收入。其中最强大的<small>CVS</small> Health 就占据了所有药品销售额的四分之一。仅三个<small>PBM</small>就处理了 80% 的处方索赔。高达 92% 的药品通过三个批发商流通。</p><p class="css-1hno3qs e190yofl0">由于核心业务的增长空间所剩无几，而且反垄断机构阻止了收购直接竞争对手的企图，寡头垄断者近年来已将业务扩展到医疗保健供应链的其他领域。除了增加收入外，这种垂直整合还可以提高利润。 2010 年《平价医疗法案》将健康保险公司的利润限制在所收保费的 15% 至 20% 之间，具体取决于健康计划的规模。但它对医生或其他中介机构的收入没有施加任何限制。</p><p class="css-1hno3qs e190yofl0">该法律激励保险公司收购诊所、药店等，并引导客户转向这些机构而不是竞争对手。该策略将利润上限的保险业务的收入引导至无上限的子公司，理论上这可以让保险公司保留更多患者支付的保费。 </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231014_EPC875.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231014_EPC875.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231014_EPC875.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231014_EPC875.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231014_EPC875.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231014_EPC875.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231014_EPC875.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231014_EPC875.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231014_EPC875.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231014_EPC875.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231014_EPC875.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231014_EPC875.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231014_EPC875.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231014_EPC875.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231014_EPC875.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231014_EPC875.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231014_EPC875.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">研究公司 Irving Levin Associates 的数据显示，2013 年至 2023 年 8 月期间，这九家医疗保健巨头花费了约 3250 亿美元进行了 130 多项并购。其中一些交易使两家公司更加深入对方的地盘。 2017 年， <small>CVS</small>斥资 780 亿美元收购大型健康保险公司、UnitedHealth 的竞争对手 Aetna。次年，另一家大型保险公司 Cigna 以 670 亿美元吞并了大型<small>PBM</small>公司 Express Scripts。 2022 年，UnitedHealth 斥资 130 亿美元收购了 Change Healthcare，这是一家数据分析公司，为该行业的大部分公司（包括 UnitedHealth 的竞争对手）处理保险索赔。</p><p class="css-1hno3qs e190yofl0"> UnitedHealth 和<small>CVS</small>也一直在收购医疗保健提供商。 Optum Health 是 UnitedHealth 的子公司，过去六年在此类交易上花费了超过 230 亿美元，目前通过 2,200 家诊所组成的网络治疗了超过 2000 万名患者。它拥有的医生数量（70,000 名受雇或附属医生）比美国最大的连锁医院还要多。 <small>CVS</small>经营着大约 1,100 家社区诊所，仅今年一年就斥资 180 亿美元收购了两家专注于利润丰厚的老年护理市场的公司。</p><p class="css-1hno3qs e190yofl0">行业高管表示，将患者护理的所有部分（初级保健诊所、药房服务、 <small>PBM</small>和保险）集中到一起对所有人都有利。大健康认为，在旧的按服务收费模式中，医生或医院为他们提供的每项服务付费，鼓励他们尽可能多地提供服务并收取尽可能多的费用。相比之下，如果医生和保险公司属于同一业务，则激励措施应该一致，总体成本应该更低。</p><p class="css-1hno3qs e190yofl0">至少理论上是这样。这有一定道理。尽管最近遇到了劳工问题，凯撒医疗机构历来被誉为高效、高质量医疗保健的榜样。其业务拥有 39 家医院和超过 24,000 名医生，高度一体化，Kaiser 的保险计划涵盖会员在其医院和诊所的治疗。今年四月，Kaiser 宣布将收购位于宾夕法尼亚州的医疗系统 Geisinger Health，以将其综合护理模式扩展到更多州。</p><p class="css-1hno3qs e190yofl0">然而，垂直整合可能会产生不利的副作用。例如，许多研究发现，医院收购医生执业后，价格会上涨，但护理质量却不会。控制患者护理许多方面的医疗保健公司可能会提高希望访问其网络的竞争对手的价格。一些人还担心医生会被迫为患者提供最便宜的治疗，从而降低护理质量。</p><p class="css-1hno3qs e190yofl0">智库布鲁金斯学会的理查德·弗兰克认为，目前还没有证据表明该模型存在问题。但在其他地方，寡头垄断行为的重大健康迹象已经显现出来。考虑<small>PBM</small> 。这些中间商因其在决定药品价格方面的作用而成为立法者和监管机构关注的焦点。至少有四项旨在监管<small>PBM 的</small>不同法案正在国会审议。近二十年来，美国主要反垄断机构联邦贸易委员会 ( <small>FTC</small> ) 一直反对加强对<small>PBM</small>监管的努力，认为此类举措会损害消费者利益。然而，2022 年 7 月， <small>FTC</small>改变策略，对最大的<small>PBMS 的商业行为展开调查。</small></p><p class="css-1hno3qs e190yofl0">问题在于<small>PBM</small>的不透明定价，它采用药品的标价，并削减<small>PBM</small>向制药商争取的折扣。 <small>PBM</small>声称它们是大型制药公司的制衡力量。但批评者认为，大型<small>PBM</small>并没有将折扣转嫁给健康计划，而是为自己保留了大部分差额，并限制了对他们来说利润较低的治疗的获得。 8 月，地区医疗保险公司 Blue Cross of California 放弃了<small>CVS</small>的<small>PBM</small> ，转而支持规模较小的公司，以节省近 500 万会员的药品成本。</p><p class="css-1hno3qs e190yofl0">事实上，美国的医疗中介机构利润异常丰厚。南加州大学的 Neeraj Sood 及其同事进行的研究发现，医疗保健供应链中的中介机构获得的年化超额回报（定义为投资资本回报率与加权平均资本成本之间的差额）为 5.9 个百分点2013 年和 2018 年，<small>标准普尔</small>500<small>指数</small>整体上升了 3.6 个百分点。</p><p class="css-1hno3qs e190yofl0">大健康的巨大超额利润终于吸引了新来者。 Bright Health Group 和 Oscar Health 等新兴健康保险公司将自己定位为透明且对消费者友好的传统保险公司替代品。马克·库班成本加成药品公司 (Mark Cuban Cost Plus Drug Company) 是一家由同名亿万富翁创办的在线药店，绕过中间商，直接从制造商那里购买更便宜的仿制药，然后以 15% 的固定加价出售给消费者。</p><p class="css-1hno3qs e190yofl0">也许对大健康的最大破坏可能来自<a href="https://www.economist.com/business/2022/11/20/amazon-makes-a-new-push-into-health-care">亚马逊</a>。 2021 年，由于与美国最大银行摩根大通及其最大投资公司伯克希尔哈撒韦公司成立的非营利性合资企业 Haven Healthcare 的关闭，该公司的医疗保健雄心遭受挫折。哈文的目标是降低这三家公司员工的医疗费用。但尽管 Haven 失败了，亚马逊仍在扩大其医疗保健业务。去年，它斥资 39 亿美元收购了初级保健提供商 One Medical。它还运营 Amazon Clinic（一项提供虚拟咨询的在线服务）和 RxPass（允许其 Prime 订阅服务的会员以少量费用购买无限量的仿制药）。亚马逊制药业务负责人约翰·洛夫 (John Love) 认为，这家科技巨头对客户体验的关注，加上其庞大的物流网络，使其非常适合撼动整个行业。</p><p class="css-1hno3qs e190yofl0">到目前为止，新来者的影响还很有限。摩根大通的丽莎·吉尔认为，他们中的大多数人都低估了健康行业的复杂性。几十年来，这些地位稳固的公司已经建立了由医生、医院、保险公司和制药商组成的网络。复制这需要时间和机构知识。库班先生承认，让制药商在他的药房列出品牌药品很困难，因为他们担心扰乱大型<small>PBM</small> 。如果没有品牌药品和大型医疗保险公司的支持，他的公司的影响力仍然很小。保险公司利润上限让该行业的新贵们日子不好过，他们很难与综合巨头的谈判能力竞争。即使代表其三位支持者的 120 万美国员工及其家人的 Haven 也没有掌握足够的市场力量来迫使医疗保健提供商降低价格。亚马逊的药房业务尚未打入美国前 15 名药房连锁店。大科技可能很强大。但就目前而言，它甚至在健康面前屈服。 <span class="ufinish">■</span></p></div> ]]>;</description><pubDate> Sun, 08 Oct 2023 17:48:45 GMT</pubDate><guid ispermalink="false"> /内容/3uoapnt8fg3kkilrgvj0bebe522li10e</guid><link/> https://www.economist.com/business/2023/10/08/who-profits-most-from-americas-baffling-health-care-system </item><item><title><![CDATA[Inside the secretive business of geopolitical advice]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/065%20Business%20-%20Business%20and%20geopolitics-3abc31f6b4b007a861ee160d191e92c0.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0">对于西方跨国公司的老板来说，<span>现在</span><small>是一个</small>焦虑的时期。在受到世界各国政府数十年的追求之后，许多人现在始终担心自己会陷入地缘政治关系紧张的交火中。日益自信的中国现在已开始对外国公司的高管实施出境禁令。最新的例子是9月29日，据报道，美国克罗尔咨询公司驻香港的重组顾问被禁止离开内地。</p><p class="css-1hno3qs e190yofl0">在中国做生意远不是唯一的担忧来源。美国首席执行官正在应对布鲁塞尔的监管热情，就像欧洲首席执行官正在应对干预主义更强的美国一样。两个组织都试图利用海湾地区的资金源泉，但又不想讨好其独裁统治者。加拿大和印度之间因一名锡克教活动人士涉嫌在加拿大境内被暗杀而发生的外交争端，将使许多西方商界大亨不寒而栗。麻烦似乎无处不在。</p><p class="css-1hno3qs e190yofl0">幸运的是，顾问行业可以帮助跨国公司穿越这些危险的水域。尽管地缘政治顾问已经存在了几十年，但由于海外开展业务日益复杂，对其服务的需求现在正在飙升。银行家、律师和管理顾问纷纷涌入这一领域。曾经是一个小众且神秘的业务正在进入专业服务的主流。</p><p class="css-1hno3qs e190yofl0">退休的政治家长期以来一直寻求利用他们的知识和外国关系来赚钱。 1982 年，前美国国务卿亨利·基辛格为此成立了基辛格协会。后来的政府也推出了自己的同类公司，从 McLarty Associates 和 Albright Stonebridge Group 到 WestExec Advisors 等等。所有这些都挤满了前政府名人。</p><p class="css-1hno3qs e190yofl0">李·范斯坦 (Lee Feinstein) 曾经是一名大使，现在为麦克拉蒂工作，他指出，许多客户都重视那些“在事情发生的房间里”的人的建议。这些公司提供的具体服务并不透明，而且各不相同，但总体范围从衡量外国政府的政策意图到帮助想要在新市场销售或制造的公司打开大门。</p><h2 class="css-8p8dhl e8f47sz0">远处的诡异动作</h2><p class="css-1hno3qs e190yofl0">这些“前任”并不是跨国公司可以获得的专业顾问的唯一来源。欧亚集团（Eurasia Group）和牛津分析公司（Oxford Analytica）等地缘政治咨询公司较少依赖退休的大人物，而更多地依赖监控全球事务并向客户提供简报的专业分析师。 （《<i>经济学</i><small>人》</small>的姊妹公司《经济学人智库》也参与了这一业务。） 另一种服务是由前英国间谍于 1995 年创立的 Hakluyt 公司提供的。它从与高层有联系的全球员工网络中获取情报，并为客户提供从监管机构对可能收购的意见到潜在供应商诚信度等各种内幕消息。该公司的执行合伙人瓦伦·钱德拉(Varun Chandra)表示，地缘政治现在几乎渗透到该公司所做的一切事情中。 （Hakluyt 的董事长也是<i>《经济学人</i>》母公司的董事长。）</p><p class="css-1hno3qs e190yofl0">近年来，寻求建议的范围不断扩大。奥尔布赖特·斯通布里奇 (Albright Stonebridge) 的艾米·塞利科 (Amy Celico) 指出，她公司的工作重点已从帮助公司向海外扩张扩大到帮助他们抵御不断恶化的地缘政治气候。越来越多的跨国公司发现自己被用作全球政治的棋子，而很少对自己有利。今年五月，中国禁止美国公司美光公司生产的存储芯片用于该国的关键基础设施。该公司四分之一的销售额来自中国，但目前预计将损失一半。顾问可以帮助企业预防此类打击，并在某些情况下游说反对它们。</p><p class="css-1hno3qs e190yofl0">地缘政治建议的重点也扩展到新兴市场之外。钱德拉先生观察到，越来越多的美国科技巨头来到哈克卢特寻求在布鲁塞尔的帮助。另一家公司的一位高管指出，美国的通货膨胀削减法案为气候友好型投资提供了大约 1 万美元的补贴，吸引了许多客户。</p><p class="css-1hno3qs e190yofl0">结果是增长激增。大多数顾问都严密保守自己的收入数据。钱德拉表示，Hakluyt 的销售额在过去四年中翻了一番，但该公司并未这样做。年轻的进入者也正在崛起。 Macro Advisory Partners 成立于 10 年前，首席执行官纳德·穆萨维扎德 (Nader Mousavizadeh) 表示，自 2018 年以来，其团队规模扩大了一倍多。</p><p class="css-1hno3qs e190yofl0">看到机会的大型企业顾问纷纷介入。管理咨询公司麦肯锡推出了地缘政治风险实践。该公司联合负责人齐亚德·海德尔 (Ziad Haider) 表示，客户的需求猛增。专业服务巨头<small>安永</small>也推出了类似的服务。</p><p class="css-1hno3qs e190yofl0">跨国律师事务所 Dentons 帮助成立了独立咨询公司 Dentons Global Advisors ( <small>DGA</small> )，该公司于 2021 年收购了 Albright <small>Stonebridge。DGA</small>的老板 Ed Reilly 解释说，其服务与执业有着“天然的联系”法律的。投资银行拉扎德也在建立地缘政治咨询业务。负责这项工作的泰迪·邦泽尔 (Teddy Bunzel) 表示，地缘政治问题已成为拉扎德大部分传统咨询工作的核心。去年10月，该银行聘请了基辛格协会前任首席执行官贾米·米西克(Jami Miscik)。</p><p class="css-1hno3qs e190yofl0">随着行业内的公司竞相争夺人才，此类举措正在频繁而迅速地发生。米西克女士认为，良好的地缘政治建议的供应受到限制。 WestExec 的管理合伙人米歇尔·弗卢努瓦 (Michèle Flournoy) 表示，她的工作“全都与人有关，而这些人是无法制造的”。但它们是可以被收购的。 <small>DGA</small>收购 Albright Stonebridge 后，McLarty 和 WestExec 分别被两家管理咨询公司 Ankura 和 Teneo 收购。欧亚大陆现已与专业服务重量级企业<small>毕马威</small>建立了合作伙伴关系。</p><p class="css-1hno3qs e190yofl0">经过多年精简公共事务部门后，许多跨国公司也一直忙于聘请地缘政治专家。赖利先生表示，此类团队正在迅速成为<small>DGA</small>最大的竞争对手。最终，这可能会迫使分散的顾问行业进行整合。目前，跨国公司的老板们越来越认识到，全球政治将决定他们未来几年的成功。 <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"><i>要掌握商业和技术领域最重大的新闻，请订阅我们的每周订阅者<a href="https://www.economist.com/newsletters/the-bottom-line">简讯“底线”</a> 。</i></p></div> ]]>;</description><pubDate> Thu, 05 Oct 2023 12:47:55 GMT</pubDate><guid ispermalink="false"> /内容/mkns5m4bavbh15c26t5f5jmfdm89q1sc</guid><link/> https://www.economist.com/business/2023/10/05/inside-the-secretive-business-of-geopolitical-advice </item><item><title><![CDATA[The Indian business of blowing things up is booming]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/066%20Business%20-%20The%20explosives%20business-0c6f2c5662782220f206a24ff9eab20c.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0">想要<span>衡量</span>印度经济前景<small>的人</small>通常会关注建造房屋、生产必需品、制造廉价车辆以及提供电力等基本服务或旅行等非必需服务的企业。这些行业目前都在发出混杂的信息——好消息足以证明希望是合理的，但也有一些警告需要谨慎。不过，有一个行业正在发出明确的信号。而且声音很大。</p><p class="css-1hno3qs e190yofl0">自四月份以来，Premier Explosives 的股价已经上涨了一倍多。自 2021 年以来，大型爆炸产品制造商 Solar Industries 的销售额已翻了两番。其他炸药生产商也享受着类似的增长势头。这种爆炸性的增长除了是送给双关语爱好者的礼物之外，还反映出这个行业的变化，它能够很好地捕捉到印度经济发展的一切趋势。 </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231007_WBC842.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231007_WBC842.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231007_WBC842.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231007_WBC842.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231007_WBC842.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231007_WBC842.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231007_WBC842.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231007_WBC842.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231007_WBC842.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231007_WBC842.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231007_WBC842.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231007_WBC842.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231007_WBC842.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231007_WBC842.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231007_WBC842.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC842.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC842.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">印度于 20 世纪 40 年代开始生产炸药，当时印度从英国获得独立。大多数工程师和技术来自英国的帝国化学工业公司。印度煤炭公司是一家国有矿业公司，处于国内能源生产和工业发展的核心地位，长期以来一直是最大的客户。由于其矿山遍布印度各地，而且过去最好避免长距离运输老式炸药，因此成立了单独的公司来为印度煤炭公司的各个地点提供服务。随着其他客户的出现，这种地理分散性得以保留，从而导致了市场的分散。如今，印度拥有 36 个大型炸药生产商。</p><p class="css-1hno3qs e190yofl0">多年来生意一直很好。最近的乐观前景源于多种因素的综合作用。印度煤炭公司的任务是满足该国不断增长的能源需求，其需求仍然强劲。国内建筑业的繁荣补充了这一点。炸药用于开采石灰石，而石灰石是制造水泥和生产钢铁所必需的。作为中央政府基础设施雄心的一部分，它们对于新道路和隧道的大规模土地清理工作也是不可或缺的。</p><p class="css-1hno3qs e190yofl0">最后，炸药制造商正受益于印度和其他地方国防开支的增加。据<i>《商业线》</i>报道，Munitions India 是 2021 年对国有控股公司进行重组而创建的公司，主要生产弹药、炸弹、火箭以及爆炸物，截至 2025 年 3 月的订单已排满。买家包括印度的 7 家公司。欧洲，四个在非洲，两个在中东。</p><p class="css-1hno3qs e190yofl0">过去，此类出口因担心运输物品可能爆炸而受到限制。生产炸药的基本原材料，例如各种硝酸盐，也广为人知并广泛可用。现代爆炸物更加稳定，这使得它们移动的危险性降低，尽管安全和环境问题导致许多国家停止国内生产。直到最近，另一个大型炸药制造商中国才获得了大量外包业务。随着地缘政治紧张局势加剧，许多客户，尤其是西方客户，正在寻找中国供应商的替代品。对 Premier 和 Solar 等公司的兴奋不会很快消失。 <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"><i>要掌握商业和技术领域最重大的新闻，请订阅我们的每周订阅者<a href="https://www.economist.com/newsletters/the-bottom-line">简讯“底线”</a> 。</i></p></div> ]]>;</description><pubDate> Thu, 05 Oct 2023 12:47:55 GMT</pubDate><guid ispermalink="false"> /内容/0ak1vrlh7u2rfjsdki4s9293n2olacpo</guid><link/> https://www.economist.com/business/2023/10/05/the-indian-business-of-blowing-things-up-is-booming </item><item><title><![CDATA[Bill Ackman wants another shot at shaking up IPOs]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/067%20Business%20-%20Public%20companies-033f814a6c126b75fc49992d5704bf5e.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0"><span>比尔</span><small>·阿克曼</small>正在寻找交易。对冲基金潘兴广场 (Pershing Square) 的老板正在寻找“大型私人成长型公司”，这些公司寻求筹集 15 亿美元或更多资金，但对传统首次公开募股 ( <small>IPO</small> ) 的“风险和费用”持谨慎态度。他的解决方案是：成立一家特殊目的收购权公司，即<small>SPARC</small> 。 9 月 29 日，监管机构批准了这种新型投资工具，阿克曼称其为比 2021 年繁荣的特殊目的收购公司 ( <small>SPAC</small> ) 更公平、更便宜的替代品。</p><p class="css-1hno3qs e190yofl0">这种金融创新有很多值得喜欢的地方。首先，与<small>SPAC</small>通过<small>IPO</small>筹集大量资金，然后在市场上寻找潜在目标不同， <small>SPARC</small>将首先找到合并候选者。有利的是，阿克曼先生有更多的时间来完成这项交易——十年，而<small>SPAC</small>则为两年。他还为潜在投资者做好了准备：潘兴广场已将<small>SPARC</small>权利免费授予其之前解散的<small>SPAC</small>的股东。潘兴广场本身最多可以保留新公司5%的股份。</p><p class="css-1hno3qs e190yofl0">一旦与目标公司达成协议， <small>SPARC</small>的股票就可以开始在交易所交易。 <small>SPARC</small>权利持有人可以在股票上市后四个星期内按照交易中约定的价格购买股票。如果投资者选择不行使这些权利，这些权利就会到期。通过承诺作为主要投资者出资 2.5 亿至 35 亿美元，潘兴广场正在调整其激励措施与投资者的激励措施。</p><p class="css-1hno3qs e190yofl0">对于公司与他的<small>SPARC 的</small>合并，阿克曼先生承诺确定性和较低的费用。在传统的首次<small>公开募股</small>中，公司筹集的资金数额只有在其股票在首次交易前定价时才能确定。相比之下，与<small>SPARC</small>合并的企业确切地知道它将筹集多少资金：这是它将与已上市的<small>SPARC</small>合并的价格。此外， <small>SPARC</small>无需向银行家支付昂贵的费用来寻找投资者和承销股票发行。 <small>SPAC</small>为其合并目标提供了同样的确定性，但除了早期支持者（或“发起人”）之外的任何人都付出了高昂的代价，因为他们获得优先认股权证（以后以设定价格购买股票的权利）。 </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231007_WBC841.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231007_WBC841.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231007_WBC841.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231007_WBC841.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231007_WBC841.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231007_WBC841.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231007_WBC841.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231007_WBC841.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231007_WBC841.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231007_WBC841.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231007_WBC841.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231007_WBC841.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231007_WBC841.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231007_WBC841.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231007_WBC841.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC841.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC841.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">对于后续的发行，阿克曼先生希望能够“滚动”第一个<small>SPARC 的</small>投资者，从而创建一个资本池，而无需支付中间人费用。他的推销也吸引了另外两个群体。第一个是初创公司的创始人，他们抱怨银行家为引导公开上市而收取的高额费用。他们还怀疑银行故意压低产品价格，以牺牲公司利益为代价，以便在开业当天吸引受青睐的客户。第二类是散户投资者，他们热衷于参与银行通常为这些客户保留的<small>首次公开募股</small>行动。</p><p class="css-1hno3qs e190yofl0">由于糟糕的股市记录（见图表）和几次引人注目的内爆， <small>SPAC</small>名声不佳。许多公司未能及时找到合并目标，不得不向股东返还现金。阿克曼的汽车能否避免同样的命运将取决于他能否真正降低成本并找到价格有吸引力的目标。许多科技初创公司在利率飙升之前以高估值筹集资金。很少有人会喜欢以更温和的估值筹集资金的公开上市。 <small>SPARC</small>可能是一个好主意。但这并不是万无一失的。 <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"><i>要掌握商业和技术领域最重大的新闻，请订阅我们的每周订阅者<a href="https://www.economist.com/newsletters/the-bottom-line">简讯“底线”</a> 。</i></p></div> ]]>;</description><pubDate> Thu, 05 Oct 2023 12:47:55 GMT</pubDate><guid ispermalink="false"> /内容/5ar224522fob2aalo3l6sp3pci5a8q1q</guid><link/> https://www.economist.com/business/2023/10/05/bill-ackman-wants-another-shot-at-shaking-up-ipos </item><item><title><![CDATA[How to make hot-desking work]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/068%20Business%20-%20Bartleby-98b5bd69d2eec78f672c527b0c33f64b.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0">曼哈顿<span>最高</span><small>的</small>私人露台属于一家名为哈德逊河贸易公司的算法交易公司。它的办公室分布在世界贸易中心三号楼顶部附近的几个楼层，与其说是工作场所，不如说是主题公园：游戏室、健身房、用餐区、令人惊叹的景色、欢乐时光和抽屉里意外地塞满了糖果，给员工带来惊喜。当你离开时，你希望自己在学校能更专注于数学。</p><p class="css-1hno3qs e190yofl0">您还会想知道，对于那些不喜欢在家工作的老板来说，大流行后办公室的一线希望之一。如果有一天进来的人减少了，至少他们不需要那么多空间：他们可以找到未分配的办公桌，公司可以节省一些钱。问题在于，轮用办公桌与两件事背道而驰，一是深深植根于人类心理，二是疫情大流行的直接后果。</p><p class="css-1hno3qs e190yofl0">首先是地域性。这是一个带有负面含义的词。它让人想起那些将信息视为值得囤积的东西、将反馈视为一种入侵的人——那种为公共冰箱中存放的物品购买挂锁的人。但领土性也是自然的。正如很难不对同事主动提出的观察感到有点恼火一样，人们也喜欢拥有一个属于自己的空间。</p><p class="css-1hno3qs e190yofl0">个性化的领域似乎与归属感相关。 20 世纪 70 年代的一项研究考察了合住房间的一年级大学生的寿命。坚持读完这一学年的人在床上方放置个人装饰品的空间是辍学者的两倍。在办公室里，工作人员也用从照片、文件到面包屑和皱巴巴的纸巾等各种物品占据了自己的领地。</p><p class="css-1hno3qs e190yofl0">英国安格利亚鲁斯金大学的艾莉森·赫斯特（Alison Hirst）对流行病前的办公桌轮用人员行为进行了一项研究，将人们分为“定居者”和“流浪者”。定居者往往较早到达或年龄较大，他们每天都试图使用同一张桌子，以便拥有一个空间和一群他们认识和喜欢的邻居。流浪者往往是较晚到达的，他们不得不浪费时间寻找桌子。坐在通常由别人占据的位置上充满了社交不适。</p><p class="css-1hno3qs e190yofl0">公司可以通过让人们预订办公桌来避免这种时间浪费——用可怕的说法来说就是“酒店式住宿”。他们可以通过要求人们每晚清理自己的空间来避免分层。在这种模式下，人们确实有自己的领地，但不是桌子，而是储物柜。想想《歌舞青春》，但没有音乐或高潮。</p><p class="css-1hno3qs e190yofl0">如果说地域性是轮用办公桌的根深蒂固的问题，那么最近的一个问题则源于疫情。雇主需要更加认真地思考为什么人们应该进行通勤。没有单一的答案。办公室是与同事进行需要身体接触的协作工作的地方。这是传播公司文化和新冠病毒的一种方式。不太直观的是，建筑师公司 Gensler 在 2022 年对美国工人进行的一项调查发现，最常见的入职原因是专注于工作。但共同的主题是，办公室不再是默认的；而是办公室。它必须具有吸引力。</p><p class="css-1hno3qs e190yofl0">这与廉价版本的轮用办公桌的情况不太一样，在这种版本中，办公室占地面积缩小，人们可以尽可能地抢占一个位置。如果队友随机分散在建筑物内，凝聚力就会受到影响；如果没有足够的会议室来满足需求，协作就会变得更加困难。公司文化可能会被吸收，但只是在每个人都感到被欺负的意义上。如果你没有突然被一个听起来像“布偶”中的烧杯的人放在身边，那么集中注意力的工作就会更容易。</p><p class="css-1hno3qs e190yofl0">对于精打细算的人来说，令人不快的结论是，当人们有足够的空间时，轮用办公桌效果最好。例如，在思科位于曼哈顿的新装修办公室中，没有人有指定的办公桌（包括老板），但有很多选择，并且鼓励人们在白天反复走动。办公室是每个人的领地。</p><p class="css-1hno3qs e190yofl0">回到纽约的哈德逊河贸易公司，员工都有自己的办公桌，而且还可以随意走动。空间感觉很充足：疫情后最新楼层的会议室席位数量与分配的座位数量大致相同。您可以使用轮用办公桌来省钱，也可以用它来创造灵活性和归属感。两者都很难做到。 <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"><b>阅读我们的管理和工作专栏作家 Bartleby 的更多内容：<br></b><i><a href="https://www.economist.com/business/article70923-prod.ece">如果好莱坞大片被翻拍为职场剧会怎样？</a> （9月28日）<br></i> <i><a href="https://www.economist.com/business/2023/09/21/why-it-is-a-bad-idea-for-managers-to-attempt-to-engineer-office-friendships">为什么管理者试图营造办公室友谊是一个坏主意</a>（9 月 21 日）<br></i><i><a href="https://www.economist.com/business/article69426-prod.ece">谁是你们公司最重要的人？</a> （9月14日）</i></p><p class="css-1hno3qs e190yofl0"><i>另：巴图比专栏如何<a href="https://www.economist.com/column-names">得名</a></i></p></div>]]>;</description><pubDate> Thu, 05 Oct 2023 12:47:55 GMT</pubDate><guid ispermalink="false"> /内容/8tnikk8ui0lqvkg8pjhmbfl2gf3fuj8a</guid><link/> https://www.economist.com/business/2023/10/05/how-to-make-hot-desking-work </item><item><title><![CDATA[Why companies still want in-house data centres]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/069%20Business%20-%20Information%20technology-0033326c2c3e797c050c7998306e27a3.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0"><span>有时</span>，云<small>似乎</small>正在吞噬企业计算。去年，全球企业在外部（或“公共”）云服务上的支出接近 2300 亿美元，而 2019 年还不到 1000 亿美元。行业三大所谓“超大规模企业”——亚马逊网络服务 ( <small>AWS</small> ) 和谷歌云平台的收入和 Microsoft Azure，每年增长超过 30%。这三家公司开始向客户提供新型人工智能（ <small>AI</small> ）工具，而大型科技公司拥有最多的开发资源。毫无疑问，简陋的本地公司数据中心的日子已经屈指可数了。 </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231007_WBC818.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231007_WBC818.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231007_WBC818.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231007_WBC818.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231007_WBC818.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231007_WBC818.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231007_WBC818.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231007_WBC818.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231007_WBC818.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231007_WBC818.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231007_WBC818.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231007_WBC818.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231007_WBC818.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231007_WBC818.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231007_WBC818.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC818.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC818.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">或者他们是吗？尽管几年前云预算超过了数据中心的内部支出，但公司仍在继续投资自己的硬件和软件。分析师公司 Synergy Research Group 估计，去年这些支出首次超过 1000 亿美元（见图 1）。特别是许多工业公司发现本地计算有其优势。日益互联的工厂和产品产生的大量数据将留在现场，贝恩咨询公司预计这些数据很快就会超过广播媒体或互联网服务的数据（见图 2）。</p><p class="css-1hno3qs e190yofl0">公共云的便利性以及由于其规模经济而带来的成本节约也有其缺点。超大规模企业的数据中心通常距离客户数据源很远。将这些数据从这个源传输到处理它们的地方（有时是半个地球之外），然后再传输回来需要时间。通常这并不重要；并非所有业务信息都对毫秒级时间敏感。但有时确实如此。 </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231007_WBC799.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231007_WBC799.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231007_WBC799.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231007_WBC799.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231007_WBC799.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231007_WBC799.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231007_WBC799.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231007_WBC799.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231007_WBC799.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231007_WBC799.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231007_WBC799.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231007_WBC799.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231007_WBC799.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231007_WBC799.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231007_WBC799.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC799.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC799.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">Many manufacturers are creating “digital twins” of their brick-and-mortar factories, to detect problems, reduce down- time and improve efficiency. They are also constantly tweaking new products under development, often using data streaming in from existing products out in the world. For all such purposes data need to be analysed in as close to real time as possible, ideally with no “jitter” (inconsistency of data transfer), data loss or service outages, all of which are surprisingly common in the public cloud. Many firms also prefer to keep any data on which they train their <small>AI</small> models close to their chest. Giordano Albertazzi, chief executive of Vertiv, which provides data-centre infrastructure, thinks this may become a competitive advantage.</p><p class="css-1hno3qs e190yofl0"> Running your own data centre close to your factory also pre-empts looming requirements on localisation and “data sovereignty” from governments afraid of letting data leak across their borders. Countries which have passed some version of data-sovereignty laws include China, where plenty of manufacturers have factories, and India (though its rules apply primarily to financial companies for now).</p><p class="css-1hno3qs e190yofl0"> It is for such reasons that industrial firms are still spending on their data centres to house the data needed to hand, while shipping off less-time-critical information to the hyperscalers. Companies that embrace this dual approach include industrial champions such as Volkswagen, a German carmaker, Caterpillar, an American maker of diggers, and Fanuc, a Japanese manufacturer of industrial robots.</p><p class="css-1hno3qs e190yofl0"> Businesses that do decide to go it alone rather than rely on the hyperscalers have several options. They can build, equip and run their own facilities. These can be large or not so large. Companies like Vertiv and Schneider Electric sell small modular data centres that can be installed at or near industrial sites and linked to the data sources using 5 <small>G</small> networks (whose range means these cannot be too far away).</p><p class="css-1hno3qs e190yofl0"> Data users can also build their own data centres but rent the servers (computer-makers such as Lenovo and Dell now offer such a service) and outsource day-to-day management to specialist firms like Serverfarm. Or they can lease space in a data centre owned and managed by someone else. Tenants typically bring their own computing and networking kit, and foot the bill for running costs (including energy). In return, the landlord guarantees basics like space, physical security, access to power and cooling.</p><p class="css-1hno3qs e190yofl0"> The decision to build or rent may depend on a user&#39;s data intensity. Consider a firm in America with a medium-sized data centre which thinks its computing load will rise roughly four-fold over a decade. In that case, building its own breaks even in seven years or so, and ends up being 5% cheaper overall than leasing, according to data from Schneider Electric. If the load remains stable, renting is the less expensive option, by a similar amount (assuming a flat cost of capital).</p><p class="css-1hno3qs e190yofl0"> Several factors may affect such calculations. The price of power,<b> </b>land, material and labour is rising. The construction of some data centres is running two years behind schedule. This is pushing up rents, which are up by more than 20% since 2021, a faster rise than for all commercial property. Upgrading to <small>AI</small> -capable servers won&#39;t be cheap, either. Counterpoint Research, another analysis firm, estimates an <small>AI</small> server is between ten and 30 times the price of a general-purpose one. The hyperscalers are buying up <small>AI</small> chips from manufacturers they already work with, such as Nvidia, leaving little for other buyers.</p><p class="css-1hno3qs e190yofl0"> The cloud giants are not standing still in other ways. In order to get closer to clients and cut jitter, they are building data centres in new places such as Saudi Arabia, South Africa and Thailand. <small>AWS</small> is selling prefabricated data centres not unlike the micro ones from Vertiv or Schneider Electric. The software arm of Toyota, a Japanese carmaker, is using <small>AWS</small> ’s fridge-size Outpost prefabs in America. The Pentagon has opted for larger <small>AWS</small> kit, the size of a shipping container. The hyperscalers&#39; <small>AI</small> prowess is likely to attract some industrial custom, too. Even so, believes Arun Shenoy of Serverfarm, which works with both hyperscalers and data users, many large firms will think twice before they stick their heads completely in the cloud. <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"> <i>To stay on top of the biggest stories in business and technology, sign up to the <a href="https://www.economist.com/newsletters/the-bottom-line">Bottom Line</a> , our weekly subscriber-only newsletter.</i></p></div> ]]>;</description><pubDate> Thu, 05 Oct 2023 12:47:55 GMT</pubDate><guid ispermalink="false"> /content/nifmntg6od3dst5qu6vdsum8bn23tnt8</guid><link/> https://www.economist.com/business/2023/10/05/why-companies-still-want-in-house-data-centres </item><item><title><![CDATA[So long iPhone. Generative AI needs a new device]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/070%20Business%20-%20Schumpeter-27f7b0470abccfff46fc2fa3290ff32b.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0"> <span>W</span> <small>HEN A BEAMING</small> Mark Zuckerberg took the stage in Menlo Park on September 27th to announce a new array of Meta products, the Facebook supremo may have buried the lead. He began talking about Quest 3, Meta&#39;s virtual-reality ( <small>VR</small> ) headset, which is understandable considering that his obsession with the metaverse is now inscribed in his company&#39;s identity. Techies, though, were more excited by what came later: an announcement that Meta, in combination with Ray-Ban, would soon launch smart glasses incorporating an artificial-intelligence ( <small>AI</small> ) virtual assistant. The specs will be able to see and hear, as well as answer their wearers&#39; questions. With luck, they will not hallucinate.</p><p class="css-1hno3qs e190yofl0"> You can be dismissive of smart glasses. They have been hyped before. But lending Meta credibility this time is the fact that the same week Open <small>AI</small> , the generative- <small>AI</small> pioneer, announced that its hit chatbot, Chat <small>GPT</small> , can now see, hear and speak, besides conversing by text. Moreover, it emerged that Open <small>AI</small> was in talks with Sir Jony Ive, Apple&#39;s former designer, to create a new gadget for the <small>AI</small> era. What form it will take is still unclear. But if the idea is to build a new consumer-electronics device better suited to the back-and-forth of seeing, talking and listening <small>AI</small> s, there is a fair chance it will no longer be reliant on the touchscreen.</p><p class="css-1hno3qs e190yofl0"> The smartphone has had a good innings. Yet you only need to talk to Sky, one of Chat <small>GPT</small> ’s new audio avatars, to feel the joy of freeing yourself from its tyranny. Your columnist got a taste when he asked Sky how she thought screens might eventually be replaced: Glasses? “Absolutely!” she enthused, “especially those equipped with augmented reality [ <small>AR</small> ] and <small>AI</small> ”. Asked whether this would be a good thing, she recommended two books that explore the enormous impact that screens have had on modern life: “The Shallows: How the Internet is Changing the Way We Think, Read and Remember” by Nicholas Carr, an American writer, and “Screened out” by Jean Baudrillard, the late French philosopher. Then, when further prompted, she summarised each in crisp, insightful language with barely a moment&#39;s hesitation. It wasn&#39;t exactly Scarlett Johansson in “Her”. But it felt like having a Stanford University intellectual murmuring in your ear.</p><p class="css-1hno3qs e190yofl0"> This is all rather refreshing. Just as the year-long excitement over “foundational” models and other mind-boggling bits of <small>AI</small> infrastructure has begun to fade, along comes the chance that gen <small>AI</small> , to use the industry shorthand,<small> </small>will unleash an onslaught of new consumer technology. Tech pundits are debating the best “form factor” for the chatbot era. Ben Thompson of Stratechery, a blog and podcast, puts it in epochal terms: “There is a hardware breakthrough waiting to happen just like the internet created the conditions for the smartphone breakthrough to happen.” The ability to talk and listen to chatbots makes Meta&#39;s bet on <small>AR</small> glasses and <small>VR</small> headsets “drastically more compelling”, he writes.</p><p class="css-1hno3qs e190yofl0"> Mr Zuckerberg was early to see this coming. He has ploughed a fortune into <small>VR</small> and <small>AR</small> despite misgivings from investors. He remains excited by the metaverse. This was clear from a remote interview he recently took part in with Lex Fridman, a podcaster, which used <small>VR</small> tools to make their virtual faces so lifelike they felt as if they were in the same room together. (As Mr Fridman quipped, it could reproduce realistic facial movements even from two famously inexpressive people.) And yet gen <small>AI</small> has so dramatically accelerated the use case for smart glasses, Mr Zuckerberg told another interviewer, that there is now “no question” they will be the bigger of the two markets. He likens <small>AR</small> specs to mobile phones and <small>VR</small> headsets to desktops. In both cases he appears to hope they will transcend screens, which he says inhabit “a completely different plane from our physical lives”.</p><p class="css-1hno3qs e190yofl0"> The two-dimensional screen is not headed for the scrap heap yet. Incumbent technologies are always hard to dislodge. Meta&#39;s mobile apps such as WhatsApp, Facebook and Instagram, with their billions of users, still dwarf <small>AI</small> s like Chat <small>GPT</small> in terms of monthly visits, and they remain dependent on smartphones. As Mark Shmulik of Bernstein, an investment firm, notes, the smartphone era has never stopped people from using <small>PC</small> s. Moreover, it will not be clear until people start buying the smart glasses from the shops how compelling a product they are.</p><p class="css-1hno3qs e190yofl0"> The business case for the all-seeing, all-hearing chatbots will also take time to emerge. Open <small>AI</small> charges $20 a month for access to its family of talking avatars; Meta&#39;s <small>AI</small> -infused smart glasses will start at $299. Yet developing them is bound to be lossmaking at first. If there ever is a case for monetising them via advertisements or virtual shopping, that will probably take years. Meta&#39;s modus operandi, after all, is to launch a consumer product, scale it up and start making money from it only if it is adopted by the masses.</p><p class="css-1hno3qs e190yofl0"> In the meantime, obvious safety concerns must be tackled. Consumer technology powered by <small>AI</small> is likely to be more immersive than social media, potentially making it even more isolating for some, or triggering unhealthy attachments. Mr Zuckerberg argues that <small>AR</small> and <small>VR</small> devices could help bring people together. But Mr Shmulik says investors will not want Meta to move too fast. “The last thing they need is another negative <small>PR</small> event where they are back in the cross hairs of regulators,” he says.</p><h2 class="css-8p8dhl e8f47sz0"> Glasses half full</h2><p class="css-1hno3qs e190yofl0"> For now Mr Zuckerberg, who this time last year was fighting fires on several fronts, looks prescient. That is largely thanks to gen <small>AI</small> . Meta&#39;s foundational model, <small>LL</small> a <small>ma</small> 2, has been an open-source hit and is underpinning the firm&#39;s consumer-tech ambitions. New devices such as smart glasses and headsets could eventually free Facebook and others from their dependence on the iPhone, where Apple has hindered their ability to track data, hurting Meta&#39;s ad business. In a backhanded compliment to Mr Zuckerberg, Apple is launching its own high-end <small>AR/VR</small> headset. The iPhone-maker, too, may be sensing the twilight of the screen era. <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"> <b>Read more from Schumpeter, our columnist on global business:<br></b> <i><a href="https://www.economist.com/business/article70922-prod.ece">Customer service is getting worse—and so are customers</a> (Sep 28th)<br></i> <i><a href="https://www.economist.com/business/2023/09/21/what-arm-and-instacart-say-about-the-coming-ipo-wave">What Arm and Instacart say about the coming IPO wave</a> (Sep 21st)<br></i> <i><a href="https://www.economist.com/business/article69620-prod.ece">The Mittelstand will redeem German innovation</a> (Sep 14th)</i></p><p class="css-1hno3qs e190yofl0"> <i>Also: If you want to write directly to Schumpeter, email him at <a href="/cdn-cgi/l/email-protection#e1928289948c9184958493a184828e8f8e8c889295cf828e8c"><span class="__cf_email__">[email protected]</span></a> . And here is <a href="https://www.economist.com/column-names">an explanation</a> of how the Schumpeter column got its name.</i></p></div> ]]>;</description><pubDate> Thu, 05 Oct 2023 12:47:55 GMT</pubDate><guid ispermalink="false"> /content/tp8gro36s363qc7i0mhm1jb8fharh33q</guid><link/> https://www.economist.com/business/2023/10/05/so-long-iphone-generative-ai-needs-a-new-device </item><item><title><![CDATA[America’s bosses grapple with threats to diversity policies]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/064%20Business%20-%20Business%20and%20society-0becbc8a46575812f8a590c66b5b5098.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0"> <span>O</span> <small>n june</small> 29 <small>th</small> America&#39;s Supreme Court ended 45 years of <a href="https://www.economist.com/united-states/2023/06/29/why-americas-supreme-court-has-ended-affirmative-action">affirmative action</a> in university admissions. The decision did not change the laws that govern companies&#39; hiring and firing decisions. But it did put wind in the sails of those who think efforts by firms to increase the <a href="https://www.economist.com/graphic-detail/2022/08/25/workplace-diversity-programmes-often-fail-or-backfire">racial diversity</a> of their workforces have already stepped beyond the rules. Bosses and their lawyers have since scrambled to make sense of the judgment&#39;s implications. One big law firm, Morrison Foerster, wrote a memo to clients after the ruling, counselling them to ensure their diversity policies do not create “unlawful preferences”.</p><p class="css-1hno3qs e190yofl0"> The firm is now alleged to have ignored its own advice. In August American Alliance for Equal Rights ( <small>AAER</small> ), an organisation run by Edward Blum, the activist who brought affirmative action to the Supreme Court, sued Morrison Foerster. <small>AAER</small> alleges that one of the firm&#39;s programmes for law students, a highly prized fellowship open only to applicants from “underrepresented” groups, illegally discriminates on the basis of race. Days later the law firm broadened the requirements of its fellowship in online advertisements.</p><p class="css-1hno3qs e190yofl0"> Morrison Foerster is not alone. In the most recent quarter chatter about diversity on big American firms&#39; earnings calls dropped by more than a third, compared with the same period last year, according to data from Bloomberg. Annual general meetings have lost their revolutionary zeal: support for proposals on social issues declined this year, and companies faced a record number of “anti-woke” proposals. Haranguing from progressives has eased ever since Joe Biden replaced the race-baiting Donald Trump in the White House in 2021. And bosses, confronted by higher interest rates, labour unrest and souring geopolitics, hardly need a lawsuit over their hiring practices.</p><p class="css-1hno3qs e190yofl0"> Companies are, then, less vocal about their diversity, equity and inclusion ( <small>DEI</small> ) initiatives, a brew of policies aimed at making workforce demography reflect more closely that of the country as a whole. Such policies are under their sternest scrutiny yet. But a closer examination suggests that businesses are not disavowing such schemes. For all the remonstrations, <small>DEI</small> is not about to die. </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231007_WBC797.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231007_WBC797.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231007_WBC797.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231007_WBC797.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231007_WBC797.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231007_WBC797.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231007_WBC797.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231007_WBC797.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231007_WBC797.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231007_WBC797.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231007_WBC797.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231007_WBC797.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231007_WBC797.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231007_WBC797.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231007_WBC797.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC797.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC797.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">Although the idea of <small>DEI</small> has been around for years in America, it gained prominence after the murder in May 2020 of George Floyd, an unarmed black man, by the police in Minneapolis. This outrage led to anti-racist protests across the country, and to a gasp of condemnation from <small>C</small> -suites. <small>DEI</small> became the toast of boardrooms, shareholder meetings and employee town halls.</p><p class="css-1hno3qs e190yofl0"> Companies rushed to disclose more details about the composition of their workforces and set public targets for the ethnic and gender mix of their workers, managers and boards (see chart 1). <small>CEO</small> s shelled out on “racial equity audits”, where a law firm tells a company how racist it is. Wannabe chief executives studying for an <small>MBA</small> at the University of Pennsylvania&#39;s prestigious Wharton School could major in <small>DEI</small> studies. A survey of several big economies in May by <small>EY</small> , a consultancy, found that 73% of 18- to 26-year-olds would prefer to work at a firm that cares about <small>DEI</small> . </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20231007_WBC796.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20231007_WBC796.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20231007_WBC796.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20231007_WBC796.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20231007_WBC796.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20231007_WBC796.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20231007_WBC796.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20231007_WBC796.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20231007_WBC796.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20231007_WBC796.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20231007_WBC796.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20231007_WBC796.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20231007_WBC796.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20231007_WBC796.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20231007_WBC796.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC796.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20231007_WBC796.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">Russell Reynolds, a headhunter, found that by 2022 three-quarters of big firms in the <small>S</small> &amp; <small>P</small> 500 index had a “chief diversity officer”. More than half of large businesses link bosses&#39; compensation to hitting <small>DEI</small> targets. According to McKinsey, a consultancy, 82% of <i>Fortune</i> 200 firms have a formal diversity programme for choosing their suppliers. Since 2020 around seven in ten new appointments to the boards of <small>S</small> &amp; <small>P</small> 500 companies have been “diverse”, which is to say not straight white men. That is up from 50% in 2018 and 38% in 2013, according to Spencer Stuart, another recruiter (see chart 2). By the end of this year, firms listed on the Nasdaq exchange are required to nominate, or explain why they have not nominated, at least one “diverse” director (rising to two over the next few years).</p><p class="css-1hno3qs e190yofl0"> Three years on from Floyd&#39;s killing, <small>DEI</small> initiatives are facing challenges on two fronts. The first, as illustrated by Morrison Foerster&#39;s predicament, is legal. Racial-discrimination cases have been a headache for companies&#39; general counsels for years. On September 28th America&#39;s Equal Employment Opportunity Commission sued Tesla, a carmaker, over alleged harassment of its black employees. Today cases alleging that <small>DEI</small> initiatives are guilty of “reverse discrimination” are as likely to keep executives awake at night. On September 30th, for example, an appeals court granted <small>AAER</small> ’s request to block a venture-capital programme open only to firms owned by black women, overturning a lower-court ruling last month that went against Mr Blum&#39;s organisation.</p><p class="css-1hno3qs e190yofl0"> Mr Blum now foresees “a renewed enthusiasm to end these racial quotas”. America First Legal, which is run by a former adviser to Mr Trump, has filed complaints against more than a dozen large American companies. Two weeks after the Supreme Court ruling ended affirmative action at universities, Republican attorneys-general from 13 states penned a letter to the chief executives of America&#39;s 100 biggest firms, chastising companies including Microsoft and Goldman Sachs for their <small>DEI</small> initiatives and threatening “serious legal consequences”.</p><p class="css-1hno3qs e190yofl0"> Ishan Bhabha of Jenner and Block, a law firm, says that the <small>DEI</small> schemes most likely to face such consequences involve the setting of quotas. The more specific a firm&#39;s <small>DEI</small> targets, and the more explicitly they are linked to executives&#39; earnings, the bigger the risk that they look like an actual quota. Many companies&#39; targets do look quite specific. A recent study by Atinuke Adediran of Fordham University analysed hundreds of <small>DEI</small> policies. It found that those which aim to achieve goals by a certain date (as when State Street, a financial firm, vowed in 2020 to triple its “Black and Latinx leadership” over three years) outnumber those which lack a clear time horizon (Procter &amp; Gamble, a consumer-goods giant, says it wants “40% representation of multicultural employees” at every management level).</p><p class="css-1hno3qs e190yofl0"> The threat of lawsuits may lead companies to adapt their <small>DEI</small> policies, not least by giving general counsels a greater say in crafting them, rather than ditch the initiatives outright. And any legal challenges will anyway take years to rumble through America&#39;s courts. In the meantime, observes Esther Lander of Akin Gump, a law firm, companies are insisting in public that they will not allow the anti- <small>DEI</small> backlash to thwart their efforts, even if they are “quietly wondering whether any of their initiatives are problematic”.</p><p class="css-1hno3qs e190yofl0"> Another challenge is a slowing economy, which might be expected to have a more immediate effect on companies&#39; diversity programmes. In leaner times shareholders usually prioritise profits above all else. Employees, including young ones who profess to caring about <small>DEI</small> , may also put material concerns ahead of moral ones if the job market tightens.</p><p class="css-1hno3qs e190yofl0"> There is some evidence of trimming in <small>DEI</small> -land. Data from Revelio Labs, a workplace-data firm, show that hiring for roles administering <small>DEI</small> programmes at <small>S</small> &amp; <small>P</small> 500 firms has slowed by half since last year. Churn among workers in such roles, both voluntary and involuntary, is around twice what it is for other positions. Other executives are feeling the pinch, too. This year uncertain “macroeconomic conditions” led Alphabet, Google&#39;s parent company, to slash the “ <small>ESG</small> bonus” it awarded senior staff by 50%, to (a still juicy) $775,000 apiece. Half of the bonus scheme&#39;s potential payout is related to meeting the tech giant&#39;s <small>DEI</small> goals (as laid out in its 115-page “diversity annual report”).</p><p class="css-1hno3qs e190yofl0"> This belt-tightening does not, however, amount to a fundamental rethink of <small>DEI</small> policies. Although some chief executives find the moral case for greater racial and gender diversity a good enough reason to pursue it, and some of their shareholders agree, the more common justification for <small>DEI</small> is its purported effect on the bottom line. Many companies invoke a series of studies by McKinsey, which found that businesses with greater ethnic, racial and gender diversity are likelier than less diverse ones to enjoy higher profits than their industry average.</p><h2 class="css-8p8dhl e8f47sz0"> Race to the top</h2><p class="css-1hno3qs e190yofl0"> The reality is more complicated. McKinsey acknowledges that “correlation does not equal causation” and that “greater gender and ethnic diversity in corporate leadership doesn&#39;t automatically translate into more profit”. Plenty of scholars who have looked for a causal link have failed to find one. A paper by Jesse Fried of Harvard Law School examines the research on which Nasdaq relied to justify its board-diversity requirements. The exchange, Mr Fried writes, focused on studies like McKinsey&#39;s while ignoring others that showed a negative effect on firms&#39; performance.</p><p class="css-1hno3qs e190yofl0"> Regardless of such scholarly reservations, much of corporate America has persuaded itself that diversity is a driver of profits. A group of 69 of America&#39;s biggest companies submitted a brief defending affirmative action to the Supreme Court as it weighed the practice&#39;s fate at universities. In it the authors declared that “racial and ethnic diversity enhance business performance”. In support, they argued that racially diverse teams make “better decisions”. The <small>HR</small> Policy Association, an organisation which represents human-resources professionals, said in its own friend-of-the-court submission that it was not aware of any credible argument that commitments to diversity “should not be vigorously pursued”. The rest of America Inc seems to agree, even if that agreement may be the result of the very groupthink that <small>DEI</small> is meant to avert. <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"> <i>To stay on top of the biggest stories in business and technology, sign up to the <a href="https://www.economist.com/newsletters/the-bottom-line">Bottom Line</a> , our weekly subscriber-only newsletter.</i></p></div> ]]>;</description><pubDate> Mon, 02 Oct 2023 20:22:35 GMT</pubDate><guid ispermalink="false"> /content/1446tkmjf960pe760eqlfh8kfp3nn8lt</guid><link/> https://www.economist.com/business/2023/10/02/americas-bosses-grapple-with-threats-to-diversity-policies </item><item><title><![CDATA[Can Europe’s power grid cope with the green transition?]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/071%20Business%20-%20Renewable%20energy-9a772b5d9331638209984a2443422c47.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0"> <span>“M</span> <small>ore <i>Energiewende</i></small> , more business for us,” says Leonhard Birnbaum, chief executive of <small>E</small> . <small>ON</small> , a German power-grid operator that enjoys a near monopoly in Europe&#39;s biggest economy. The set of policies and timetables to which he is referring (and which translates to “energy turning-point”) was first unveiled in 2000 with the aim of making Germany a net-zero emitter of carbon by 2045. It is meant to increase the demand for and the supply of green power exponentially. And it can only work so long as that power can reliably flow from wind and solar farms to users in Germany and the rest of Europe.</p><p class="css-1hno3qs e190yofl0"> This presents an enormous opportunity for <small>E</small> . <small>ON</small> —and an equally formidable challenge. The energy transition requires huge investments in German and European grids, and it requires them right now. That will only happen if the government and regulators fundamentally change the way they deal with power-grid projects, notably by cutting red tape and speeding up permitting for grid expansion and reinforcement. “The limits of infrastructure are the biggest obstacle of Europe&#39;s green transition,” says Mr Birnbaum. At the moment, he explains, the grid expansion can barely cope with the huge surge of producers of renewable energy trying to connect to it.</p><p class="css-1hno3qs e190yofl0"> To illustrate the scale of the task, Mr Birnbaum points out that one charging station for electric cars with 15 outlets needs as much power as a town of 5,000 inhabitants. A new data centre needs as much power as 80,000 households. As a result, electricity consumption in Europe is forecast to increase by around 60% by the end of the decade. And whereas before the <i>Energiewende</i> Europe had 200-300 power plants, in October <small>E.ON</small> expects the millionth electricity generator to hook up to its German grid.</p><p class="css-1hno3qs e190yofl0"> “The challenges of the energy transition make Mr Birnbaum one of Germany&#39;s most political chief executives, along with Markus Krebber,” says Ingo Speich of Deka, an investment fund that owns 1% of <small>e.ON</small> . Mr Krebber runs <small>rwe</small> , a big German power producer (and <small>E</small> . <small>ON</small> ’s largest shareholder,<small> </small>with a 15% stake). Mr Birnbaum admits he still “too often” finds himself in Berlin, a six-hour drive away from <small>E</small> . <small>ON</small> ’s headquarters in Essen, talking to policymakers. But at least the coalition government is listening to his concerns, he reports.</p><p class="css-1hno3qs e190yofl0"> Policymakers in Brussels are on the case, too—at least on paper. Earlier this month Kadri Simson, the <small>EU</small> ’s energy commissioner, lamented in the <i>Financial Times</i> that securing permits for grid reinforcements can take up to ten years in Europe. Without certainty about connection to the grid, she warned, renewables projects were being abandoned. Existing clean-power capacity is underutilised. Solar panels, for instance, are frequently switched off when grids are overloaded, because they are flexible and easy to manage. “This is wasteful and costly,” Ms Simson wrote.</p><p class="css-1hno3qs e190yofl0"> While Mr Birnbaum waits for German and <small>EU</small> regulators to untangle the bureaucracy—a process that, he complains, remains far too selective—his company is starting to ramp up investments. These will add up to €33bn ($35bn) over the next five years, up from an earlier plan to spend €20bn. Most of that will go to its grids, which account for 72% of <small>E</small> . <small>ON</small> ’s turnover. </p><iframe type="youtube" src="https://www.youtube.com/embed/8OzwQoPH8ao?enablejsapi=1" class="css-xm8n1m e195f1ec0"></iframe><p class="css-1hno3qs e190yofl0"> Among other things, each year Mr Birnbaum is planning to replace between 6,000 and 7,000 of the company&#39;s 100,000 or so analogue transformers, which convert high-voltage power from the grid to voltages needed in homes, with advanced models that monitor performance and detect faults before they occur. Mr Birnbaum is keen on software that can strengthen networks without extra physical infrastructure by optimising the management of solar and wind power&#39;s variable output. “A bigger system with much more renewable energy can only be run digitally,” says Mr Birnbaum. He calls such “smart grids” the basis of 21st-century society.</p><p class="css-1hno3qs e190yofl0"> After a difficult 2022, when investors fretted about the impact of the energy crisis caused by Russia&#39;s invasion of Ukraine, <small>E</small> . <small>ON</small> ’s share price has rallied by nearly 20% this year. That has given Mr Birnbaum some room for manoeuvre. But if €584bn-worth of grid investments is to materialise by 2030, which Ms Simson estimates is necessary to meet the <small>EU</small> ’s climate goals, he will need a lot more of it. This means more visits to Berlin and Brussels. <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"> <i>For more coverage of climate change, sign up for the <a href="https://www.economist.com/newsletters/the-climate-issue">Climate Issue</a> , our fortnightly subscriber-only newsletter, or visit our <a href="https://www.economist.com/climate-change">climate-change hub</a> .</i></p></div> ]]>;</description><pubDate> Thu, 28 Sep 2023 14:10:08 GMT</pubDate><guid ispermalink="false"> /content/o6glsol88kvdu0mt283vub3hlvcqq1at</guid><link/> https://www.economist.com/business/2023/09/28/can-europes-power-grid-cope-with-the-green-transition </item><item><title><![CDATA[What if Hollywood blockbusters were remade as workplace dramas?]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/073%20Business%20-%20Bartleby-749733ad72966c5290f33da0a552ac28.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0"> <span>T</span> <small>he office</small> is not the most promising setting for films. Desk warriors can occasionally be caught up in dramatic stories, whether journalists (“Spotlight”), lawyers (“Dark Waters”) or whistleblowers (“The Informant”). The greed and fear of high finance (“Dumb Money”) have an enduring appeal. But office-based blockbusters are still pretty thin on the ground: typing, malfunctioning toilets and meetings are just not that exciting.</p><p class="css-1hno3qs e190yofl0"> There is a simple fix. Take film titles that have already done well with cinema-goers and tweak their plots for the white-collar workplace. Here are pitches for a few such remakes:</p><p class="css-1hno3qs e190yofl0"> <b>“A Quiet Place”.</b> A newly refitted office contains several small rooms that are expressly designed for focused work. But it rapidly becomes clear that demand for these rooms exceeds supply. In the rush among employees to book them or grab them when they become free, things turn very nasty indeed. Genre: horror/office administration.</p><p class="css-1hno3qs e190yofl0"> <b>“The Terminal”.</b> An office worker logs into the Bloomberg terminal for the first time in the hope of quickly finding some information. She finds that it does not respond to normal commands. Several years later, she has neither been able to locate any data nor managed to log off.</p><p class="css-1hno3qs e190yofl0"> <b><small>“</small> TED <small>”.</small></b> John is a 40-year-old man who once gave a talk at a <small>TED</small> event. He seems unable to move on from this career highlight, even though the rest of the world has. He talks only in 18-minute monologues that always start with a personal anecdote. When he speaks, he invariably stands up, paces from side to side and ends each sentence staring purposefully into the middle distance. His family and friends find him completely insufferable and all desert him.</p><p class="css-1hno3qs e190yofl0"> <b>“Avatar”.</b> A group of early adopters are given digital alter egos as they prepare to visit another world. They are promised all manner of wonderful experiences in this realm, but feel only disappointment when they find that they have no legs and the one person there is Mark Zuckerberg.</p><p class="css-1hno3qs e190yofl0"> <b>“14 Peaks</b> ”. They said it couldn&#39;t be done. But one man believes that it is possible to go to Davos 14 times in a row without completely losing his sanity. Can he survive repeated exposure to Will.i.am, Klaus Schwab and John Kerry? Viewer discretion advised: features distressing scenes of breakfast panels about <small>AI</small> .</p><p class="css-1hno3qs e190yofl0"> <b>“Goodwill Hunting”.</b> A cleaner at the offices of a hedge fund has a preternatural talent for accounting. One evening he comes across the accounts of a target company and sees immediately that it has overvalued the intangible assets on its balance-sheet. Finance-based suspense from the same team that brought you “Negative Jaws” and “Tombstone”.</p><p class="css-1hno3qs e190yofl0"> <b><small>“</small> IT <small>”.</small></b> The screen goes blank just as a board meeting is about to begin. The directors panic and press various buttons but all they manage to do is turn off the lights. Only one department can help sort out the chaos. Likely to be the longest-running film franchise in history.</p><p class="css-1hno3qs e190yofl0"> <b>“The Matrix”.</b> On the surface it looks like a normal company. But a change to reporting lines causes utter confusion. Nobody knows what is happening; several people lose their grip on reality. Not science fiction.</p><p class="css-1hno3qs e190yofl0"> <b>“World War Z”.</b> A new generation of workers is entering the office. They spend most of their time staring at their phones and laughing to themselves, but occasionally whip themselves into a state of outrage about something or other. Older workers panic about the impact these creatures will have on the company until they realise they were not that different when they were young.</p><p class="css-1hno3qs e190yofl0"> <b>“Taken”.</b> Of all the hot desks in the office one is especially sought after. It offers privacy, splendid views of the city and good air-conditioning. Nancy, a mild-mannered customer-service agent, is incensed by the tactics her colleagues use to take the desk. Things again turn very nasty. From the same team that brought you “A Quiet Place”.</p><p class="css-1hno3qs e190yofl0"> <b>“Fish Tank”.</b> The office&#39;s reception area is due for a refit. In an extraordinary piece of documentary film-making, the audience follows the facilities team as it decides to install Europe&#39;s largest aquarium. Features profanity, substance abuse and graphic violence.</p><p class="css-1hno3qs e190yofl0"> <b>“The Remains of the Day”.</b> It&#39;s four in the afternoon and Nigel, a mild-mannered actuary, has done his work for the day. He could start out on a new project, but decides to while away the time instead. Unbearably slow-moving drama.</p><p class="css-1hno3qs e190yofl0"> You can&#39;t just slap a big title on something and hope for the best, surely? If it&#39;s good enough for promoting people, it might work for films, too. <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"> <b>Read more from Bartleby, our columnist on management and work:<br></b> <i><a href="https://www.economist.com/business/2023/09/21/why-it-is-a-bad-idea-for-managers-to-attempt-to-engineer-office-friendships">Why it is a bad idea for managers to attempt to engineer office friendships</a> (Sep 21st)<br></i> <i><a href="https://www.economist.com/business/article69426-prod.ece">Who is the most important person in your company?</a> (Sep 14th)<br></i><i><a href="https://www.economist.com/business/2023/09/07/networking-for-introverts-a-how-to-guide">Networking for introverts: a how-to guide</a> (Sep 7th)</i></p><p class="css-1hno3qs e190yofl0"> <i>Also: How the Bartleby column <a href="https://www.economist.com/column-names">got its name</a></i></p></div> ]]>;</description><pubDate> Thu, 28 Sep 2023 14:10:08 GMT</pubDate><guid ispermalink="false"> /content/aq2b3ot9ir2hdivfc0408kqr3b8oo7af</guid><link/> https://www.economist.com/business/2023/09/28/what-if-hollywood-blockbusters-were-remade-as-workplace-dramas </item><item><title><![CDATA[Pharma’s big push for a new generation of obesity drugs]]></title><description><![CDATA[<div class="css-1746s8a e1ey6m752"><div class="css-1lm38nn e50l3u40"><figure><div><figcaption>听听这个故事。</figcaption><span class="css-1fs0t47 ed4dtdz0">在<a id="audio-ios-cta" href="https://economist-app.onelink.me/d2eC/bed1b25">iOS</a>或<a id="audio-android-cta" href="https://economist-app.onelink.me/d2eC/7f3c199">Android</a>上享受更多音频和播客。</span> </div><audio class="react-audio-player " id="audio-player" src="https://www.economist.com/media-assets/audio/074%20Business%20-%20Health%20care-5e8130699a00ca08a1182fe86f5c96de.mp3"><p>您的浏览器不支持<audio>元素。</p></audio></figure></div><p class="css-1hno3qs e190yofl0"> <span>F</span> <small>IVE YEARS</small> ago Novo Nordisk was a boring Danish drugmaker whose diabetes medications were reliably profitable. The only time the company made headlines was when it was caught up in complaints about the high cost of insulin. Then in 2021 a trial of a higher dose of its diabetes drug, Ozempic, showed that people taking it lost weight. A great deal of weight—up to 15% of their body mass. Excitement about the drug has kept Novo Nordisk in the headlines. Its market value has nearly quadrupled in the past five years. Earlier this month it reached $444bn, handbagging <small>LVMH</small> , a purveyor of luxury goods, off its perch as Europe&#39;s most valuable company. Novo Nordisk&#39;s main rival, Eli Lilly, which has a similar drug called Mounjaro (tirzepatide), is worth $522bn, more than four times what it was at the start of 2019.</p><p class="css-1hno3qs e190yofl0"> It isn&#39;t just investors who are jubilant. Not long ago Morgan Stanley, a bank, estimated that global sales of such weight-management drugs could reach $54bn annually by 2030. Now it puts the figure at $77bn. By comparison, last year they raked in just $2.4bn. The potential bonanza is attracting imitators. These include big pharma (for instance, Amgen, Boehringer Ingelheim and Pfizer), not-so-big pharma (Jiangsu Hengrui, Structure Therapeutics) and biotech startups (Carmot Therapeutics in California, Gmax Biopharm and Sciwind Biosciences in Hangzhou). </p><div class="css-1bzwzkr eitqf4z1"><figure class="css-qts40t e1197rjj0"><img alt width="608" sizes="300px" srcset="https://www.economist.com/cdn-cgi/image/width=16,quality=80,format=auto/content-assets/images/20230930_WBC753.png 16w, https://www.economist.com/cdn-cgi/image/width=32,quality=80,format=auto/content-assets/images/20230930_WBC753.png 32w, https://www.economist.com/cdn-cgi/image/width=48,quality=80,format=auto/content-assets/images/20230930_WBC753.png 48w, https://www.economist.com/cdn-cgi/image/width=64,quality=80,format=auto/content-assets/images/20230930_WBC753.png 64w, https://www.economist.com/cdn-cgi/image/width=96,quality=80,format=auto/content-assets/images/20230930_WBC753.png 96w, https://www.economist.com/cdn-cgi/image/width=128,quality=80,format=auto/content-assets/images/20230930_WBC753.png 128w, https://www.economist.com/cdn-cgi/image/width=256,quality=80,format=auto/content-assets/images/20230930_WBC753.png 256w, https://www.economist.com/cdn-cgi/image/width=360,quality=80,format=auto/content-assets/images/20230930_WBC753.png 360w, https://www.economist.com/cdn-cgi/image/width=384,quality=80,format=auto/content-assets/images/20230930_WBC753.png 384w, https://www.economist.com/cdn-cgi/image/width=480,quality=80,format=auto/content-assets/images/20230930_WBC753.png 480w, https://www.economist.com/cdn-cgi/image/width=600,quality=80,format=auto/content-assets/images/20230930_WBC753.png 600w, https://www.economist.com/cdn-cgi/image/width=834,quality=80,format=auto/content-assets/images/20230930_WBC753.png 834w, https://www.economist.com/cdn-cgi/image/width=960,quality=80,format=auto/content-assets/images/20230930_WBC753.png 960w, https://www.economist.com/cdn-cgi/image/width=1096,quality=80,format=auto/content-assets/images/20230930_WBC753.png 1096w, https://www.economist.com/cdn-cgi/image/width=1280,quality=80,format=auto/content-assets/images/20230930_WBC753.png 1280w, https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20230930_WBC753.png 1424w" src="https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20230930_WBC753.png"><figcaption class="css-18w36g1 edweubf2"><span class="css-6pzdis edweubf1">图片：经济学人</span></figcaption></figure></div><p class="css-1hno3qs e190yofl0">It is not the first time in pharmaceutical history that a class of drugs has been ignored, only to spur a gold rush when a successful medicine emerges. The arrival of Prozac (fluoxetine) in 1987 spawned many competitors, leading to the broad range of similar antidepressants available today. The weight-management newcomers will be hoping their drugs can, like some of Prozac&#39;s rivals, improve on the first-movers.</p><p class="css-1hno3qs e190yofl0"> One important improvement would be a drug that can be gulped down rather than injected, as Mounjaro and Ozempic&#39;s weight-loss version, Wegovy, need to be. Pfizer&#39;s needle-free option, danuglipron, is in the second phase of clinical trials (out of the necessary three). The company is expected to announce plans for further trials later this year.</p><p class="css-1hno3qs e190yofl0"> A lot of effort is also going into limiting the drugs&#39; side effects. The ones currently available make many people feel nauseous. That may lead some patients to stop taking them—a problem, given that their fat-suppressing effect wears off as soon as they are no longer administered. Novo Nordisk is experimenting with adding a hormone called amylin, which it hopes might make Wegovy more tolerable.</p><p class="css-1hno3qs e190yofl0"> Efforts are under way, too, to make the drugs more effective and longer-acting. Work is going into testing whether they can help patients counteract compulsive behaviour other than overeating, such as alcoholism. And trials are being conducted to see whether they bring broader health benefits. One recent trial showed that Wegovy was able to reduce the risk of death from heart attacks, strokes and other cardiovascular causes by 20%.</p><p class="css-1hno3qs e190yofl0"> Just how useful the drugs will prove beyond helping people lose weight remains unclear. Despite Wegovy&#39;s promising trial, Airfinity, a firm of analysts, recently calculated that 63 people would need to be treated with it over three years at a combined cost of $1.1m to prevent one cardiovascular death. However, more data on the medical benefits of these drugs could also add to their perceived value.</p><p class="css-1hno3qs e190yofl0"> This in turn would make them more palatable to those who foot the bill, such as public health-care systems or private health insurers. Those payers are nervous about the high cost, particularly as the drugs must, in their current iteration, be taken indefinitely. In Europe prices range from €170 to €357 ($180 to $375) a month. In America the list price of Wegovy is about $1,350 a month. Health insurers are cautious: so far only 40m of the 110m Americans with obesity have access to the drugs through their health insurance.</p><p class="css-1hno3qs e190yofl0"> Raymond Stevens, boss of Structure Therapeutics, says that the long-run future of pricing remains hazy. Competition from firms like his could force prices down. On the other hand, innovations in delivery or tolerability could lift them back up. The short term is more predictable. Despite Eli Lilly&#39;s and Novo Nordisk&#39;s efforts to ramp up production, demand from an overweight world will continue to outstrip supply. That is a formula for healthy profits. <span class="ufinish">■</span></p><p class="css-1hno3qs e190yofl0"> <i>To stay on top of the biggest stories in business and technology, sign up to the <a href="https://www.economist.com/newsletters/the-bottom-line">Bottom Line</a> , our weekly subscriber-only newsletter.</i></p></div> ]]>;</description><pubDate> Thu, 28 Sep 2023 14:10:08 GMT</pubDate><guid ispermalink="false"> /content/1bkqhletbsk4j7ko3dtvp1op2h8vvrn2</guid><link/> https://www.economist.com/business/2023/09/28/pharmas-big-push-for-a-new-generation-of-obesity-drugs</item></channel></rss>